日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mirvetuximab soravtansine for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer

Mirvetuximab soravtansine 用于治疗上皮性卵巢癌、输卵管癌或原发性腹膜癌

Silverstein, Jordyn; Smick, Alexandra; Johnson, Bridget; Konecny, Gottfried E

Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263)

一项随机 III 期临床试验的患者报告结果,该试验比较了辅助放疗与放化疗对接受初始根治性子宫切除术和盆腔淋巴结清扫术的中危 I/IIA 期宫颈癌患者的疗效 (NRG/GOG-0263)

Chase, Dana M; Huang, Helen Q; Deng, Wei; Koh, Wui-Jin; Rodgers, William; Small, William Jr; Albuquerque, Kevin; Mayadev, Jyoti; Leath, Charles A; Monk, Bradley; Kim, Beob-Jong; Kim, Dae-Yeon; Cho, Chi Heum; Kim, Jae-Weon; No, Jae Hong; Holman, Laura; Stuckey, Ashley; Fabian, Denise; Smick, Alexandra H; Wenzel, Lari; Gil, Karen; Ryu, Sang Young

Antiplasmodial peptaibols act through membrane directed mechanisms

抗疟原虫肽类药物通过膜导向机制发挥作用。

Jennifer E Collins ,Jin Woo Lee ,Frances Rocamora ,Gagandeep S Saggu ,Karen L Wendt ,Charisse Flerida A Pasaje ,Sebastian Smick ,Natalia Mojica Santos ,Raphaella Paes ,Tiantian Jiang ,Nimisha Mittal ,Madeline R Luth ,Taylor Chin ,Howard Chang ,James L McLellan ,Beatriz Morales-Hernandez ,Kirsten K Hanson ,Jacquin C Niles ,Sanjay A Desai ,Elizabeth A Winzeler ,Robert H Cichewicz ,Debopam Chakrabarti

Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation

强效酰基辅酶 A 合成酶 10 抑制剂通过破坏甘油三酯形成杀死恶性疟原虫

Selina Bopp, Charisse Flerida A Pasaje, Robert L Summers, Pamela Magistrado-Coxen, Kyra A Schindler, Victoriano Corpas-Lopez, Tomas Yeo, Sachel Mok, Sumanta Dey, Sebastian Smick, Armiyaw S Nasamu, Allison R Demas, Rachel Milne, Natalie Wiedemar, Victoria Corey, Maria De Gracia Gomez-Lorenzo, Virgini